StockData

KALA BIO, Inc. (KALA) shareholders

KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30
$3.43−0.40 (-10.44%)

Close on Nov 17, 2026Market cap $66.34MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
3.2%
1M of 19M shares
Institutional holders
13
4 new, 18 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
David E. Lazar49,500,0005.18%13D (active)Jan 30, 2026
Julian C. Baker
Joint filing with Baker Bros. Advisors LP (9.99%), Baker Bros. Advisors (GP) LLC (9.99%) and 1 more
2,890,0559.99%13G (passive) amendmentDec 31, 2025
LifeSci Capital LLC
Joint filing with Andrew McDonald (7.90%), Michael Rice (7.90%)
2,200,0007.90%13G (passive)Dec 30, 2025
Oxford Finance LLC1,620,00016.50%13G (passive)Nov 25, 2025
Labkowski Nachum966,9915.00%13G (passive)Oct 14, 2026
Baker Bros. Advisors (GP) LLC
Joint filing with Baker Bros. Advisors LP (9.99%), Julian C. Baker (9.99%) and 1 more
744,7599.99%13G (passive)Oct 2, 2025
Felix J. Baker
Joint filing with Baker Bros. Advisors LP (9.99%), Baker Bros. Advisors (GP) LLC (9.99%) and 1 more
744,7599.99%13D (active) amendmentSep 30, 2025
Bihua Chen
Joint filing with Cormorant Asset Management, LP (9.99%)
609,0279.99%13G (passive)Dec 31, 2024
Steven A. Cohen
Joint filing with Point72 Asset Management, L.P. (6.70%), Point72 Capital Advisors, Inc. (6.70%)
469,2296.70%13G (passive)Sep 4, 2025
Simeon George
Joint filing with SR One Capital Fund II Aggregator, LP (5.50%), SR One Capital Partners II, LP (5.50%) and 1 more
411,0005.50%13D (active) amendmentSep 29, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of KALAValueChange% of portfolio
Vanguard Capital Management LLC220,6231.14%$381.68K+219,4120.00%
Geode Capital Management, LLC145,1520.75%$251.11K+139,9310.00%
Vanguard Fiduciary Trust Co101,3960.52%$175.42K+100,8030.00%
BlackRock, Inc.71,5420.37%$123.77K+71,3260.00%
Northern Trust Corp41,6060.22%$71.98K+41,3760.00%
Qube Research & Technologies Ltd11,0730.06%$19.16KNew0.00%
Goldman Sachs Group Inc10,9210.06%$18.89K+10,6400.00%
UBS Group AG9,0570.05%$15.67K+7,7200.00%
Tower Research Capital LLC (TRC)6160.00%$1.07KNew0.00%
Barclays PLC6080.00%$1.05KNew0.00%
Morgan Stanley280.00%$48−310.00%
Caitong International Asset Management Co., Ltd100.00%$17New0.00%
International Assets Investment Management, LLC20.00%$4–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026131M3.2%4 / 71 / 181M0M
Q1 2026270M0.2%8 / 82 / 80M0M
Q4 2025290M0.3%11 / 37 / 40M0M
Q3 2025220M0.2%5 / 94 / 100M0M
Q2 2025280M0.4%5 / 74 / 40M0M
Q1 2025270M0.4%5 / 82 / 90M0M
Q4 2024320M0.4%8 / 74 / 20M0M
Q3 2024260M0.2%5 / 44 / 60M0M
Q2 2024280M0.2%5 / 85 / 50M0M
Q1 2024280M0.1%4 / 48 / 00M0M
Q4 2023240M0.1%2 / 72 / 30M0M
Q3 2023250M0.1%1 / 56 / 30M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

6 funds held KALA in Q2 2026, 96% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of KALAValue% of fundAs of
Vanguard Extended Market Index Fund220,6231.14%$381.68K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund5,6330.03%$12.56K0.00%May 31, 2026
Fidelity Extended Market Index Fund3,8220.02%$8.52K0.00%May 31, 2026
Total Stock Market Index Trust3550.00%$6140.00%Jun 30, 2026
Fidelity Total Market Index Fund2360.00%$5260.00%May 31, 2026
Fidelity Series Total Market Index Fund1520.00%$3390.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Avraham MinkowitzChief Executive Officer, Director––Feb 9, 2026
David E. LazarChief Executive Officer, Director0–Dec 22, 2025
Romulus K. BrazzellSEE REMARKS35,9520.19%Oct 24, 2025
Mary ReumuthCHIEF FINANCIAL OFFICER28,9060.15%Oct 24, 2025
Darius KharabiCHIEF BUSINESS OFFICER41,7600.22%Oct 24, 2025
Brendan P. PurdyDirector––Feb 9, 2026
Yonatan C. ColmanDirector––Feb 9, 2026
Chaim D. BergerDirector––Feb 9, 2026
Hillel D. PosenDirector––Feb 9, 2026
Todd BazemoreDirector35,9330.19%Oct 24, 2025
Mark T. IwickiDirector103,5400.54%Oct 24, 2025
Andrew I. KovenDirector16,9720.09%Jun 17, 2025
Howard B. RosenDirector16,5020.09%Jun 17, 2025
Gregory D. PerryDirector13,3440.07%Jun 17, 2025
C. Daniel MyersDirector10,3740.05%Jun 17, 2025
Marjan FaridDirector10,2420.05%Jun 17, 2025
Finance Llc Oxford10% owner1,620,0008.38%Dec 3, 2025
Bros. Advisors Lp Baker–––Oct 2, 2025
Bros. Advisors (GP) LLC Baker–––Oct 2, 2025
Felix Baker–118,4960.61%Oct 2, 2025
Julian Baker–46,4800.24%Oct 2, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Mark T. Iwicki
Director
Oct 23, 2025Sale−154,894$0.81$125.46K103,540
Mary Reumuth
CHIEF FINANCIAL OFFICER
Oct 23, 2025Sale−967$0.82$79328,906
Romulus K. Brazzell
SEE REMARKS
Oct 22, 2025Sale−46,748$0.83$38.80K35,952
Darius Kharabi
CHIEF BUSINESS OFFICER
Oct 22, 2025Sale−20,806$0.83$17.27K41,760
Todd Bazemore
Director
Oct 22, 2025Sale−47,768$0.83$39.65K35,932
Mary Reumuth
CHIEF FINANCIAL OFFICER
Oct 22, 2025Sale−32,230$0.83$26.75K29,873
Julian Baker
–
Oct 1, 2025Sale−50,640$1.38$69.88K46,480
Julian Baker
–
Oct 1, 2025Sale−462,967$1.38$638.89K425,006
Julian Baker
–
Sep 30, 2025Sale−195,425$1.60$312.68K887,973
Julian Baker
–
Sep 30, 2025Sale−21,376$1.60$34.20K97,120
Todd Bazemore
SEE REMARKS
Jun 24, 2025Sale(10b5-1 plan)−4,058$4.01$16.27K83,699
Darius Kharabi
CHIEF BUSINESS OFFICER
Jun 24, 2025Sale(10b5-1 plan)−4,511$4.01$18.09K62,566
Romulus K. Brazzell
SEE REMARKS
Jun 24, 2025Sale(10b5-1 plan)−5,251$4.01$21.06K82,698
Mark T. Iwicki
Director
Jun 24, 2025Sale(10b5-1 plan)−13,227$4.01$53.04K258,433
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jun 24, 2025Sale(10b5-1 plan)−3,631$4.01$14.56K62,100
Gregory D. Perry
Director
Jun 15, 2025Award+2,450––13,344
Howard B. Rosen
Director
Jun 15, 2025Award+2,450––16,240
Marjan Farid
Director
Jun 15, 2025Award+2,450––10,242
C. Daniel Myers
Director
Jun 15, 2025Award+2,450––10,374
Andrew I. Koven
Director
Jun 15, 2025Award+3,050––16,972
Mark T. Iwicki
Director
Jun 15, 2025Award+2,450––271,660
Mark T. Iwicki
Director
Jun 3, 2025Sale(10b5-1 plan)−10,866$3.74$40.64K269,210
Darius Kharabi
CHIEF BUSINESS OFFICER
Jun 3, 2025Sale(10b5-1 plan)−730$3.74$2.73K67,077
Romulus K. Brazzell
SEE REMARKS
Jun 3, 2025Sale(10b5-1 plan)−3,687$3.74$13.79K87,949
Mark T. Iwicki
Director
Jun 3, 2025Sale(10b5-1 plan)+10,866$3.74$40.64K269,210
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jun 3, 2025Sale(10b5-1 plan)−2,850$3.74$10.66K65,731
Todd Bazemore
SEE REMARKS
Jun 3, 2025Sale(10b5-1 plan)−3,390$3.74$12.68K87,757
Romulus K. Brazzell
SEE REMARKS
Jan 6, 2025Sale(10b5-1 plan)−2,446$7.63$18.66K92,418
Romulus K. Brazzell
SEE REMARKS
Jan 6, 2025Award+10,100––94,864
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
Jan 6, 2025Award+22,100––285,855
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
Jan 6, 2025Sale(10b5-1 plan)−5,779$7.63$44.09K280,076
Todd Bazemore
SEE REMARKS
Jan 6, 2025Sale(10b5-1 plan)−1,993$7.63$15.21K–
Todd Bazemore
SEE REMARKS
Jan 6, 2025Award+10,100–––
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jan 6, 2025Sale(10b5-1 plan)−1,706$7.63$13.02K68,581
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jan 6, 2025Award+10,100––70,287
Darius Kharabi
CHIEF BUSINESS OFFICER
Jan 6, 2025Award+10,100––69,828
Darius Kharabi
CHIEF BUSINESS OFFICER
Jan 6, 2025Sale(10b5-1 plan)−2,021$7.63$15.42K67,807
Felix Baker
10% owner
Dec 30, 2024Buy+30,620$6.44$197.19K118,496
Felix Baker
10% owner
Dec 30, 2024Buy+279,939$6.44$1.80M1,083,398
Romulus K. Brazzell
SEE REMARKS
Jun 26, 2024Sale(10b5-1 plan)−5,489$4.75$26.07K83,982
Darius Kharabi
CHIEF BUSINESS OFFICER
Jun 26, 2024Sale(10b5-1 plan)−5,158$4.75$24.50K59,728
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jun 26, 2024Sale(10b5-1 plan)−4,163$4.75$19.77K60,187
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
Jun 26, 2024Sale(10b5-1 plan)−15,168$4.75$72.05K263,755
Todd Bazemore
SEE REMARKS
Jun 26, 2024Sale(10b5-1 plan)−4,653$4.75$22.10K83,040
Mark S. Blumenkranz
Director
Jun 11, 2024Award+1,400––13,091
Andrew I. Koven
Director
Jun 11, 2024Award+1,750––13,922
Howard B. Rosen
Director
Jun 11, 2024Award+1,400––13,887
C. Daniel Myers
Director
Jun 11, 2024Award+1,400––7,924
Marjan Farid
Director
Jun 11, 2024Award+1,400––7,792
Gregory D. Perry
Director
Jun 11, 2024Award+1,400––10,894
Darius Kharabi
CHIEF BUSINESS OFFICER
May 31, 2024Sale(10b5-1 plan)−231$6.09$1.41K64,886
Romulus K. Brazzell
SEE REMARKS
May 31, 2024Sale(10b5-1 plan)−2,002$6.09$12.19K89,471
Todd Bazemore
SEE REMARKS
May 31, 2024Sale(10b5-1 plan)−2,093$6.09$12.75K87,693
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
May 31, 2024Sale(10b5-1 plan)−7,392$6.09$45.02K278,923
Mary Reumuth
CHIEF FINANCIAL OFFICER
May 31, 2024Sale(10b5-1 plan)−1,786$6.09$10.88K64,350
Romulus K. Brazzell
SEE REMARKS
Jan 4, 2024Sale(10b5-1 plan)−1,617$6.74$10.90K91,473
Romulus K. Brazzell
SEE REMARKS
Jan 4, 2024Award+6,500––93,090
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
Jan 4, 2024Sale(10b5-1 plan)−4,539$6.73$30.55K286,315
Mark T. Iwicki
CHIEF EXECUTIVE OFFICER, Director
Jan 4, 2024Award+14,300––290,854
Mary Reumuth
CHIEF FINANCIAL OFFICER
Jan 4, 2024Sale(10b5-1 plan)−1,227$6.74$8.27K66,136

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
1.98%
0M shares short
Days to cover
1.8
At 0M shares a day
Change since last report
-29.0%
From 1M shares
Short volume, 20 days
41.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kala Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 364,612 shares on Oct 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Andrew I. Koven
Director
Mar 17, 202614,466$3.82KMar 17, 2026Restricted Stock
Charles D Myers
Director
Mar 12, 20269,112$2.86KMar 12, 2026Restricted Stock
Howard B. Rosen
Director
Mar 12, 202613,576$3.98KMar 12, 2026Restricted Stock
Mark T. Iwicki
Director
Oct 23, 2025154,894$125.19KOct 23, 2025Restricted Stock
Mary Reumuth
Officer
Oct 23, 2025967$793Oct 23, 2025Exercised Shares
R K Brazzell
Officer
Oct 22, 202546,748$38.96KOct 22, 2025Performance Shares
Todd Bazemore
Officer
Oct 22, 202547,768$39.69KOct 22, 2025Restricted Stock
Darius Kharabi
Officer
Oct 22, 202520,806$17.28KOct 22, 2025Restricted Stock
Mary Reumuth
Officer
Oct 22, 202532,230$26.73KOct 22, 2025Restricted Stock
Todd Bazemore
Officer
Jun 24, 20254,058$16.27KJun 24, 2025Restricted Stock Unit Vesting
Mary Reumuth
Officer
Jun 24, 20253,631$14.56KJun 24, 2025Restricted Stock Unit Vesting
Mark T. Iwicki
Director
Jun 24, 202513,227$53.04KJun 24, 2025Restricted Stock Unit Vesting
Romulus K. Brazzell
Officer
Jun 24, 20255,251$21.06KJun 24, 2025Restricted Stock Unit Vesting
Darius Kharabi
Officer
Jun 24, 20254,511$18.09KJun 24, 2025Restricted Stock Unit Vesting
Mark T. Iwicki
Director
Jun 3, 202510,866$40.64KJun 3, 2025Restricted Stock Unit Vesting

See a number that looks wrong?